DISEASE BURDEN & HIGH IMPACT VACCINATION

GLOBAL BURDEN

Global burdenGlobal Burden Dengue is an epidemic-prone disease spread by mosquitoes and is common in tropical climates. It comes in 4 serotypes, similar but different, all of which circulate in endemic areas, each of which can make a person sick.  It causes high fevers and lots of pain, and severe infections can lead to hospitalizations or even life-threatening dengue hemorrhagic fever.  There is no specific treatment.  Dengue’s reach is vast and it is growing further: it is present in 128 countries around the world and over half the world’s population lives in areas where dengue is endemic, with global incidence up 50% in the last 30 years.   Costs of dengue can be staggering: $9 billion USD annually in direct medical and indirect costs.   Ubiquitous, complex diseases like this require an integrated disease prevention strategy.  This includes clinical diagnosis, case management, mosquito vector control, personal protection against mosquito bites, community awareness, and where available, vaccination.

BURDEN BY COUNTRY

Philippines

Burden by country - PhilippinesAsia bears 70%(3) of the global disease burden. Learn more about the disease burden in the Philippines, the first country in Asia to license and introduce the first dengue vaccine.

Download infographic

Mexico

Burden by country - MexicoDengue is a major public health concern in Mexico.  The dengue vaccine was licensed there first in December 2015.  Vaccinations began in September 2016.

Download infographic

Brazil

Burden by counrty - BrazilTwo-thirds of all dengue cases in Latin America occur in Brazil, with millions of cases occurring yearly.  Parana state, Brazil launched the first public dengue vaccination program in Latin America in July 2016.

Download infographic